Skip to content
Checked.be
Complete company report
Generated 16-07-2026
Active BE 0450.108.506Public limited company

SEBARIC

Klaprozenpad 6 ·8301 Knokke-Heist, Belgium· 33 yrs active
Sector: Human health (86220)
Conclusion Checked

The computed 12-month bankruptcy probability of SEBARIC is < 0.1% (very low). The 2025 annual accounts show equity of €1.26M and a net result of €-39k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 47% of 2191 sector peers (fiscal year 2025). The company has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 8 annual accounts.
Key figures
Equity €1.26M
Net result €-39k
Better than sector 47%
Active 33 yrs
Snowflake analysis 5 axes · computed by Checked
Health60Profitability0Solvency96Growth52Stability100
62 / 100

Strong profile, led by stability.

Health 60
Profitability 0
Solvency 96
Growth 52
Stability 100
Bankruptcy probability (12 mo) Checked model v1 · free
< 0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Long track record −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 3 signals
Long-established
Founded in 1993, 33 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags 0 events
No administrative flags
Health barometer FY 2025 · computed
60 / 100 Healthy
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Financial overview10 NBB filings
Annual accounts filed on 12-03-2026 with the NBB · fiscal year 2025 · micro
€-200k€-100k€0Operating result 2021: €22k€22kNet result 2021: €-20k€-20kOperating result 2022: €21k€21kNet result 2022: €-2k€-2kOperating result 2023: €49k€49kNet result 2023: €18k€18kOperating result 2024: €-190k€-190kNet result 2024: €-168k€-168kOperating result 2025: €10k€10kNet result 2025: €-39k€-39k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable Equity: stable across 8 fiscal years (±0.3%/year).
€1.20M€1.30M€1.40M€1.50M2026: €1.42M (€1.32M - €1.52M)2027: €1.42M (€1.32M - €1.52M)2028: €1.42M (€1.31M - €1.52M)2018: €1.23M2019: €1.47M2020: €1.44M2021: €1.45M2022: €1.45M2023: €1.47M2024: €1.30M2025: €1.26M20182019202020212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 53.3% 58.0%
better than 47% of 2191 sector peers
Net result €-39k €60k
better than 5% of 2189 sector peers
Equity €1.26M €74k
better than 95% of 2191 sector peers
Gross operating margin €76k €96k
better than 40% of 2191 sector peers
Total assets €2.37M €186k
better than 95% of 2191 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€69k
+24.2% +3% vs sector
Net profit
€-39k
+76.8% far below sector median
Cash flow
€20k
-74.1% -63% vs sector
Total assets
€2.37M
-21.8% far above sector median
Equity
€1.26M
-3.0% far above sector median
Working capital
€385k
-63.5% far above sector median
Income taxes
€32k
+142.4% +44% vs sector
Debt
€1.11M
-35.9% far above sector median
Debt ≤ 1y
€28k
-23.9% -18% vs sector
Debt > 1y
€1.08M
-36.2% far above sector median
Current ratio
14.89
-50.4% far above sector median
Quick ratio
14.89
-50.4% far above sector median
Solvency
53.3%
+24.0% -29% vs sector
Debt / equity
0.88
-33.9% +168% vs sector
ROE
-3.1%
+76.1% far below sector median
ROA
-1.7%
+70.3% far below sector median
Interest coverage
0.96
+42.3% -93% vs sector
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€69k
Net profit€-39k
Cash flow€20k
Staff costs-
Income taxes-
Dividends-
Total assets€2.37M
Equity€1.26M
Debt€1.11M
of which ≤ 1y€28k
of which > 1y€1.08M
Working capital€385k
Employees (FTE)-
Ratios (computed)
2025
Current ratio14.89
Quick ratio14.89
Working capital ratio16.3%
Solvency53.3%
Debt / equity0.88
Long-term debt ratio0.86
Interest coverage0.96
Gross margin-
Net margin-
ROA-1.7%
ROE-3.1%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€2.37M
Fixed assets 21/28€1.96M
Tangible fixed assets 22/27€1.96M
Financial fixed assets 28€19
Current assets 29/58€413k
Amounts receivable within one year 40/41€16k
Investments 50/53€368k
Cash & bank 54/58€28k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€2.37M
Equity 10/15€1.26M
Contributions / capital 10/11€166k
Reserves 13€1.07M
Accumulated profits (losses) 14€24k
Amounts payable 17/49€1.11M
Amounts payable after one year 17€1.08M
Amounts payable within one year 42/48€28k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€76k
Operating result 9901€10k
Financial income 75€23k
Financial charges 65€73k
Result before taxes 9903€-39k
Net result for the period 9904€-39k
Result to be appropriated 9905€-39k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.
Legal Structure
NACE primary Human health(86220)
Legal form Public limited company(014)
Incorporation13-05-1993
StatusActive
Postal code8301
Establishment units 1 location
SEBARIC NV
Klaprozenpad 6, 8301 Knokke-Heistde verwerking van bloed
since 19932.062.483.680
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31337F0287/00C000 Flanders 1,021 m² 1 · 191 m² 13.1 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 11 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
12-03-2026
NBB filing Annual accounts filed
fiscal year 2025 · micro
2025
18-04-2025
State Gazette act Director changes
13-03-2025
NBB filing Annual accounts filed
fiscal year 2024 · micro
2024
12-03-2024
NBB filing Annual accounts filed
fiscal year 2023 · micro
2023
03-01-2023
NBB filing Annual accounts filed
fiscal year 2022 · micro
2022
19-04-2022
NBB filing Annual accounts filed
fiscal year 2021 · micro
2021
10-03-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
2020
06-01-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
2019
15-03-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
2018
14-03-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
2017
01-02-2017
NBB filing Annual accounts filed
fiscal year 2016 · verkort
Belgisch Staatsblad, acts 1 acts
All acts · 1 updated 1 year ago
2025
18-04-2025 2 directors appointed Director changes
  • Kathleen De Vrieze, Bestuurder
  • Kathleen De Vrieze, Gedelegeerd bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kathleen De Vrieze",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Er blijkt uit de notulen van de Algemene Vergadering gehouden op 11/03/2025 dat er met eenparigheid van stemmen werd beslist te herbenoemen als bestuurder en gedelegeerd bestuurder tot de algemene vergadering in 2031:",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2031"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Kathleen De Vrieze",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Er blijkt uit de notulen van de Algemene Vergadering gehouden op 11/03/2025 dat er met eenparigheid van stemmen werd beslist te herbenoemen als bestuurder en gedelegeerd bestuurder tot de algemene vergadering in 2031:",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2031"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "GENT",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-04-18",
    "filing_date": "2025-04-10",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2025-03-11",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0450.108.506",
    "name_full": "SEBARIC",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Kathleen De Vrieze",
    "org_rep_person_name": null,
    "person_role_at_subject": "Gedelegeerd Bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.
Company registry (CBE) Crossroads Bank
Activities
Medische praktijken85120Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
Legal nameNL SEBARIC
Registered office
Klaprozenpad 6 bus 21
8301 Knokke-Heist, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same NACE
Chirurgie Oculaire Docteurs PRIJOT et LEROY BE 0443.487.364 · Liège
GASTRO MEDICAL ASSISTANCE BE 0463.165.397 · Anderlecht
Nat. Centrum ter Voorkoming en Behandeling van Intoxicaties BE 0409.140.951 · Brussel
CARDIOMEDICALE BE 0463.677.024 · Namur
DR. FRANK PROVENIER CARDIOLOOG BE 0466.557.033 · Maldegem
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative